Skip to main content
PMC home page
Journal of Epidemiology and Community Health logoLink to Journal of Epidemiology and Community Health
. 2003 Aug;57(8):571–578. doi: 10.1136/jech.57.8.571

Chasing Ernst L Wynder: 40 years of Philip Morris' efforts to influence a leading scientist

N Fields 1, S Chapman 1
PMCID: PMC1732529  PMID: 12883059

Abstract

Study objective: To highlight strategies used by the Philip Morris tobacco company to try to manipulate the eminent scientist, Dr Ernst Wynder between 1955 and 1995.

Methods: Systematic keyword and opportunistic searching of www.pmdocs.com for formerly internal tobacco industry documents concerning Philip Morris executives and Wynder. Available materials included reports, budget reviews, and correspondence.

Main results: The emergence of smoking as a priority issue on the American public health agenda can be largely attributed to Wynder's research and publicity efforts. Philip Morris viewed Wynder as a prestigious scientist whose commitment to the pursuit of reduced harm cigarettes could lend legitimacy to its desire to position itself as a responsible company intent on addressing consumer concerns. Philip Morris courted Wynder with large equipment loans and grants for more than 30 years, and used its public relations agency to sanitise press releases to remove material unacceptable to the company. Wynder consistently failed to acknowledge industry support while routinely acknowledging other funding from the National Cancer Institute and the American Cancer Society. In retrospect, Wynder realised the insidious effect of tobacco industry research support but failed to acknowledge this may have applied to his own association with the industry.

Conclusions: Industry documents reveal a deliberate attempt by Philip Morris to pursue and manipulate Dr Wynder to legitimise their company positions.

Full Text

The Full Text of this article is available as a PDF (131.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Augustine A., Harris R. E., Wynder E. L. Compensation as a risk factor for lung cancer in smokers who switch from nonfilter to filter cigarettes. Am J Public Health. 1989 Feb;79(2):188–191. doi: 10.2105/ajph.79.2.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Augustine A., Hebert J. R., Kabat G. C., Wynder E. L. Bladder cancer in relation to cigarette smoking. Cancer Res. 1988 Aug 1;48(15):4405–4408. [PubMed] [Google Scholar]
  3. Barnes D. E., Bero L. A. Industry-funded research and conflict of interest: an analysis of research sponsored by the tobacco industry through the Center for Indoor Air Research. J Health Polit Policy Law. 1996 Fall;21(3):515–542. doi: 10.1215/03616878-21-3-515. [DOI] [PubMed] [Google Scholar]
  4. Cohen J. E. Universities and tobacco money. BMJ. 2001 Jul 7;323(7303):1–2. doi: 10.1136/bmj.323.7303.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Doll R. Tobacco: an overview of health effects. IARC Sci Publ. 1986;(74):11–22. [PubMed] [Google Scholar]
  6. Francey N., Chapman S. "Operation Berkshire": the international tobacco companies' conspiracy. BMJ. 2000 Aug 5;321(7257):371–374. doi: 10.1136/bmj.321.7257.371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hecht S. S., Carmella S. G., Murphy S. E., Akerkar S., Brunnemann K. D., Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med. 1993 Nov 18;329(21):1543–1546. doi: 10.1056/NEJM199311183292105. [DOI] [PubMed] [Google Scholar]
  8. Hoffman D., Masuda Y., Wynder E. L. Alpha-naphthylamine and beta-naphthylamine in cigarette smoke. Nature. 1969 Jan 18;221(5177):255–256. doi: 10.1038/221254a0. [DOI] [PubMed] [Google Scholar]
  9. Hoffmann D., Adams J. D., Wynder E. L. Formation and analysis of carbon monoxide in cigarette mainstream and sidestream smoke. Prev Med. 1979 May;8(3):344–350. doi: 10.1016/0091-7435(79)90011-2. [DOI] [PubMed] [Google Scholar]
  10. Hoffmann D., Wynder E. L. Chemical constituents and bioactivity of tobacco smoke. IARC Sci Publ. 1986;(74):145–165. [PubMed] [Google Scholar]
  11. Hoffmann D., Wynder E. L., Rivenson A., LaVoie E. J., Hecht S. S. Skin bioassays in tobacco carcinogenesis. Prog Exp Tumor Res. 1983;26:43–67. doi: 10.1159/000407252. [DOI] [PubMed] [Google Scholar]
  12. Hoffmann D., Wynder E. L. Smoking and occupational cancers. Prev Med. 1976 Jun;5(2):245–261. doi: 10.1016/0091-7435(76)90043-8. [DOI] [PubMed] [Google Scholar]
  13. Hoffmann DH. Ernst L wynder MD DrSc hc (mult) Dr med hc, 1922-1999. Tob Control. 1999 Winter;8(4):444–445. doi: 10.1136/tc.8.4.444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kabat G. C., Wynder E. L. Lung cancer in nonsmokers. Cancer. 1984 Mar 1;53(5):1214–1221. doi: 10.1002/1097-0142(19840301)53:5<1214::aid-cncr2820530532>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  15. Peto J., Doll R. Passive smoking. Br J Cancer. 1986 Sep;54(3):381–383. doi: 10.1038/bjc.1986.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Thun M. J., Burns D. M. Health impact of "reduced yield" cigarettes: a critical assessment of the epidemiological evidence. Tob Control. 2001;10 (Suppl 1):i4–11. doi: 10.1136/tc.10.suppl_1.i4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. WYNDER E. L., GRAHAM E. A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of 684 proved cases. J Am Med Assoc. 1950 May 27;143(4):329–336. doi: 10.1001/jama.1950.02910390001001. [DOI] [PubMed] [Google Scholar]
  18. WYNDER E. L., HOFFMANN D. REDUCTION OF TUMORIGENICITY OF CIGARETTE SMOKE: AN EXPERIMENTAL APPROACH. JAMA. 1965 Apr 12;192:88–94. doi: 10.1001/jama.1965.03080150018003. [DOI] [PubMed] [Google Scholar]
  19. Wynder E. L., Covey L. S., Mabuchi K. Current smoking habits by selected background variables: Their effect on future disease trends. Am J Epidemiol. 1974 Sep;100(3):168–177. doi: 10.1093/oxfordjournals.aje.a112025. [DOI] [PubMed] [Google Scholar]
  20. Wynder E. L., Goodman M. T. Smoking and lung cancer: some unresolved issues. Epidemiol Rev. 1983;5:177–207. doi: 10.1093/oxfordjournals.epirev.a036258. [DOI] [PubMed] [Google Scholar]
  21. Wynder E. L., Hebert J. R., Kabat G. C. Association of dietary fat and lung cancer. J Natl Cancer Inst. 1987 Oct;79(4):631–637. [PubMed] [Google Scholar]
  22. Wynder E. L., Mabuchi K. Lung cancer among cigar and pipe smokers. Prev Med. 1972 Dec;1(4):529–542. doi: 10.1016/0091-7435(72)90035-7. [DOI] [PubMed] [Google Scholar]
  23. Wynder E. L. Tobacco and health: a review of the history and suggestions for public health policy. Public Health Rep. 1988 Jan-Feb;103(1):8–18. [PMC free article] [PubMed] [Google Scholar]
  24. Wynder E. L. Tobacco as a cause of lung cancer: some reflections. Am J Epidemiol. 1997 Nov 1;146(9):687–694. doi: 10.1093/oxfordjournals.aje.a009342. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Epidemiology and Community Health are provided here courtesy of BMJ Publishing Group

RESOURCES